About the Study

RSV, Respiratory Syncytial Virus, is a very common, highly contagious virus that causes infection of the respiratory tract in people of all ages. In the Rochester climate, symptoms usually develop during fall and winter. In many people, the disease is quite mild and can produce cold-like symptoms. However, in very young children, older adults, and people with chronic diseases such as COPD, it can be very serious and result in hospitalization or death. There is currently no vaccine available to the general public to prevent this infection and antibiotics are not helpful as this infection is viral.

RCR will be conducting RSV vaccine studies in the near future in an effort to help find a safe and effective vaccine for RSV.

Compensation is available for time and travel is available for those who qualify. Study-related care is available to participants at no cost and health insurance is not required nor needed.

If you are interested in joining a future RSV vaccine study at RCR, enter your information and we will call you when a study begins enrolling.